Physician profile
Ari Sapin
NPI 1487018305
$19,772.74
in general payments reported to CMS, 2019-2025
11 companies · $2,726 in 2025
The $2,726 reported for 2025 was more than what 85% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,614 · 2022: $448 · 2023: $8,584 · 2024: $5,402 · 2025: $2,726.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $14K · Food and Beverage: $1,622 · Travel and Lodging: $1,079 · Consulting Fee: $430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $13,580.00 |
| Food and Beverage | $1,622.05 |
| Travel and Lodging | $1,078.96 |
| Consulting Fee | $430.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,315.38 | 2021-2023 | Davinci Xi, Da Vinci Surgical System, Da Vinci Sp |
| Baxter Healthcare | $7,911.58 | 2021-2025 | Floseal, Tisseel, Peri-Strips Dry |
| Medtronic, INC. | $1,762.94 | 2021-2025 | Sonicision, Signia, Ligasure |
| W. L. Gore & Associates, INC. | $402.20 | 2021-2022 | |
| Teleflex LLC | $188.03 | 2024-2025 | Titan Sgs, Titan Sgs Bailout Chuck |
| Ethicon US, LLC | $59.84 | 2021-2022 | |
| Becton, Dickinson and Company | $37.55 | 2025 | Phasix Mesh |
| Takeda Pharmaceuticals U.S.A., INC. | $32.15 | 2025 | Gattex |
| Vertex Pharmaceuticals Incorporated | $23.75 | 2025 | |
| Merck Sharp & Dohme LLC | $21.44 | 2024 | Bridion |
| Lilly USA, LLC | $17.88 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ari Sapin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.